ATE482927T1 - Neues opioidderivat - Google Patents

Neues opioidderivat

Info

Publication number
ATE482927T1
ATE482927T1 AT03703014T AT03703014T ATE482927T1 AT E482927 T1 ATE482927 T1 AT E482927T1 AT 03703014 T AT03703014 T AT 03703014T AT 03703014 T AT03703014 T AT 03703014T AT E482927 T1 ATE482927 T1 AT E482927T1
Authority
AT
Austria
Prior art keywords
hydrogen atom
opioid derivative
new opioid
new
derivative
Prior art date
Application number
AT03703014T
Other languages
English (en)
Inventor
Yoshio Okada
Yuko Tsuda
Toshio Yokoi
Sharon Bryant
Lawrence Lazarus
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Application granted granted Critical
Publication of ATE482927T1 publication Critical patent/ATE482927T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03703014T 2002-01-29 2003-01-22 Neues opioidderivat ATE482927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/058,192 US6838580B2 (en) 2002-01-29 2002-01-29 Opioid derivative
PCT/JP2003/000516 WO2003064375A1 (en) 2002-01-29 2003-01-22 New opioid derivative

Publications (1)

Publication Number Publication Date
ATE482927T1 true ATE482927T1 (de) 2010-10-15

Family

ID=27658228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03703014T ATE482927T1 (de) 2002-01-29 2003-01-22 Neues opioidderivat

Country Status (6)

Country Link
US (1) US6838580B2 (de)
EP (1) EP1470101B1 (de)
JP (1) JP4467985B2 (de)
AT (1) ATE482927T1 (de)
DE (1) DE60334362D1 (de)
WO (1) WO2003064375A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN101065014A (zh) * 2004-09-23 2007-10-31 亚历山大·米哈洛 通过诱导逆适应调节神经递质系统的方法
US8030341B2 (en) 2005-09-01 2011-10-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Dmt-derivative compounds and related compositions and methods of use
US11104763B2 (en) 2017-04-06 2021-08-31 Alliance For Sustainable Energy, Llc Renewable polymers and resins and methods of making the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3585936D1 (de) * 1984-09-20 1992-06-04 Erba Carlo Spa Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
US5272175A (en) * 1992-05-20 1993-12-21 G. D. Searle & Co. Substituted tyrosyl diamide compounds
DE60006032T2 (de) * 1999-05-28 2004-06-17 Pfizer Products Inc., Groton 3-(3-Hydroxyphenyl)-3-amino-propionamidderivate
JP2001122895A (ja) 1999-10-20 2001-05-08 Hamari Chemicals Ltd 新規なオピオイドペプチド誘導体
JP2002069059A (ja) * 2000-08-28 2002-03-08 Teikoku Seiyaku Co Ltd ピラジノン環を含む新規なオピオイドペプチド誘導体

Also Published As

Publication number Publication date
JP4467985B2 (ja) 2010-05-26
JP2005516060A (ja) 2005-06-02
DE60334362D1 (de) 2010-11-11
EP1470101A4 (de) 2006-08-16
US6838580B2 (en) 2005-01-04
EP1470101B1 (de) 2010-09-29
EP1470101A1 (de) 2004-10-27
US20030171302A1 (en) 2003-09-11
WO2003064375A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2005240213A8 (en) Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
TW200637559A (en) 3-propenylcefem derivative
SG161302A1 (en) DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE ss2 ADRENERGIC RECEPTOR
BR0013251A (pt) Derivado de isoxazolina e herbicida que contém o mesmo como ingrediente ativo
DE602005005854D1 (de) Organopolysiloxan und dieses enthaltende härtbare silikonzusammensetzung
RS51943B (en) PIPERIDINSKI GPCR AGONIST
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
AU7824900A (en) Compounds and methods for inhibiting mrp1
GEP20074215B (en) Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof
MY140749A (en) Novel piperidine compound
RS50229B (sr) Analozi vitamina d3
WO2008149834A1 (ja) ピリミドジアゼピノン誘導体
ATE482927T1 (de) Neues opioidderivat
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
NO20053208L (no) Metode for reduktiv dehalogenering.
EA200001134A1 (ru) Вакцина
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
CA2440186A1 (en) Medicinal composition containing 1,3-thiazine derivative
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
DE602004004093D1 (de) Alkylierte iminodibenzyle als antioxidationsmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties